Drug loss from Paclitaxel-Coated Balloons During Preparation, Insertion and Inflation for Angioplasty: A Laboratory Investigation
Open Access
- 10 June 2022
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (8) , 1186-1197
Abstract
Purpose: To investigate drug contamination of the working environment with paclitaxel drug-coated balloon (DCB) angioplasty due to loss of paclitaxel containing particles from the coating during DCB preparation, insertion, and inflation. Material and Methods: In an experimetal laboratory setting, drug loss during removal of the protective cover and insertion of the DCB through the hemostatic valve of the introducer sheath and after inflation was examined. In seven DCB types of different manufacturers, semi-quantitative image analysis was performed during five standardized tests cycles. Additionally, every DCB type passed one cycle of a wipe test and one cycle of air sampling. Results: By removing the protective cover, the paclitaxel-covered balloon surface was significantly reduced in 3 out of 7 products (P = 0.043). Overall, extend of decline ranged from 0.4 to 12%. In 6 of 7 products, powdered paclitaxel clusters dropped down upon removal of the protective cover (0.099 ng/cm2 up to approx. 22 ng/cm2). Contamination of the air was detected in none of the DCB types. When pushed through the vascular sheath, none of the investigated DCB types showed a significant loss of paclitaxel from the coated balloon surface. After balloon inflation, the paclitaxel-coated surface area varied between manufacturers ranging from 25.9 to 97.8%. Conclusion: In some DCB types, the removal of the protective cover already leads to a significant loss of paclitaxel and paclitaxel-coated surfaces. As a result, there will be a contamination of the workplace and a reduction in the therapeutic dose. Level of Evidence: No level of evidence.Keywords
Funding Information
- Friedrich-Schiller-Universität Jena
This publication has 20 references indexed in Scilit:
- Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery DiseaseJournal of Endovascular Therapy, 2016
- Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine StudyCardioVascular and Interventional Radiology, 2016
- In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloonsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Pharmacokinetic Study of Paclitaxel Concentration after Drug-Eluting Balloon Angioplasty in the Iliac Artery of Healthy and Atherosclerotic Rabbit ModelsJournal of Vascular and Interventional Radiology, 2015
- Correlating Coating Characteristics with the Performance of Drug-Coated Balloons – A Comparative In Vitro Investigation of Own Established Hydrogel- and Ionic Liquid-Based Coating MatricesPLOS ONE, 2015
- TCT-289 Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon CathetersJACC, 2014
- Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healingOpen Heart, 2014
- In Vitro Determination of Drug Transfer from Drug-Coated BalloonsPLOS ONE, 2013
- Application and Assessment of a Regular Environmental Monitoring of the Antineoplastic Drug Contamination Level in Pharmacies - The MEWIP ProjectAnnals of Occupational Hygiene, 2012
- Dose Response to Paclitaxel-Coated Balloon Catheters in the Porcine Coronary Overstretch and Stent Implantation ModelInvestigative Radiology, 2011